Ahead of his Ophthalmologica Lecture at the Euretina Congress in Vienna, Dr. Elon van Dijk (The Netherlands) joins Ophthalmologica Editor-in-Chief Prof. Martin Zinkernagel (Switzerland) to explain why central serous chorioretinopathy remains so hard to pin down — and what multimodal imaging can tell us about which eyes will resolve on their own. They discuss the evidence behind half-dose PDT, the trials that got us there, and the career choices behind the lecture
Members can continue the conversation in the Euretina Forum.
Browse all podcast episodes here.
Listen on your preferred podcast player:
